Olfactory Disturbances as Presenting Manifestation Among Egyptian Patients with COVID-19: Possible Role of Zinc
- 7 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Biological Trace Element Research
- Vol. 199 (11), 4101-4108
- https://doi.org/10.1007/s12011-020-02546-5
Abstract
COVID-19 is a severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2). Deficiency of zinc has been supposed to contribute to loss of smell and taste in COVID-19 patients. Our study aimed to assess the serum zinc levels among patients with COVID-19 of various severities, with and without olfaction dysfunction, and to evaluate the effect of zinc therapy in recovery of smell dysfunction among such patients. This study included 134 patients; real-time reverse transcription-polymerase chain reaction (rRT-PCR) proved SARS-CoV-2. Serum zinc levels were measured for all infected patients. One hundred and five patients were detected to have anosmia and/or hyposmia and were categorized randomly into 2 groups; the first group included 49 patients who received zinc therapy and the second group included 56 patients who did not received zinc. All patients were followed up for the recovery duration of olfactory and gustatory symptoms and duration of complete recovery of COVID-19. Olfactory dysfunction was reported in 105 patients (78.4%). Serum zinc levels were not significantly different between the patient subgroups regarding disease severity or the presence or absence of olfactory and/or gustatory dysfunction (p ˃ 0.05). The median duration of recovery of gustatory and/or olfactory function was significantly shorter among patients who received zinc therapy than those who did not received zinc (p < 0.001), while the median duration of complete recovery from COVID-19 was not significantly different among the two groups (p ˃ 0.05). Although the zinc status of COVID-19 patients did not exhibit a significant role in development of anosmia and/or hyposmia or disease severity, zinc therapy may have a significant role in shortening the duration of smell recovery in those patients without affecting the total recovery duration from COVID-19.Keywords
This publication has 60 references indexed in Scilit:
- Discovery of Human Zinc Deficiency: Its Impact on Human Health and DiseaseAdvances in Nutrition: An International Review Journal, 2013
- Pharmaco-nutrient interactions - a systematic review of zinc and antihypertensive therapyInternational Journal of Clinical Practice, 2012
- A Randomized, Placebo Controlled Trial of Oral Zinc for Chemotherapy-Related Taste and Smell DisordersJournal of Pain & Palliative Care Pharmacotherapy, 2012
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell CulturePLoS Pathogens, 2010
- Methods of assessment of zinc status in humans: a systematic reviewThe American Journal of Clinical Nutrition, 2009
- Pathogen Recognition and Innate ImmunityCell, 2006
- Zinc Potentiates the Antiviral Action of Human IFN-αTenfoldJournal of Interferon & Cytokine Research, 2001
- The Diagnosis of a Conductive Olfactory LossThe Laryngoscope, 2001
- Zinc Supplementation Reconstitutes the Production of Interferon-α by Leukocytes from Elderly PersonsJournal of Interferon & Cytokine Research, 1997
- Evaluation of olfactory dysfunction in the connecticut chemosensory clinical research centerThe Laryngoscope, 1988